Marketresearchnews

Monday, 12 July 2021

Nerve Regeneration Market Foraying into Emerging Economies 2020-2027

Market Highlights

The Global Nerve Regeneration Market Report by MRFR estimated to be valued at USD 12695.25 Million by 2024 and is projected to register a CAGR of 11.34% during the forecast period.

Nerve regeneration products are used to restore damaged nerves to their normal function, and this procedure is primarily used to treat peripheral nerve injuries. Hence the increasing geriatric population prone to nerve-related disorders, rising prevalence of neurological disorders, and technological advancements ultimately have a positive impact on the global nerve regeneration market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1202

The rising neurological disorders, increasing geriatric population, technological advancements are anticipated to drive the market growth. However, the high cost of these products and services along with a stringent regulatory framework are projected to hamper the market growth.

Segment Analysis

The global nerve regeneration market has been segmented based on product, application, and end user. Based on product, the market has been segregated into neurostimulation and neuromodulation devices, and biomaterials. Based on neurostimulation and neuromodulation devices, the market has been divided into internal neurostimulation devices and external neurostimulation devices. Internal neurostimulation devices has been further bifurcated into spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, sacral nerve stimulation, and gastric Electrical Stimulation. External neurostimulation devices has been further segmented into transcutaneous electrical nerve stimulation and transcranial magnetic stimulation. Biomaterials has been further divided into nerve conduits, nerve protectors, and nerve wraps, nerve connectors. Based on application, the market has been classified as neurostimulation and neuromodulation surgeries, direct nerve repair/neurorrhaphy, nerve grafting, stem cell therapy, and others. Neurostimulation and neuromodulation surgeries has been categorized as internal neurostimulation and neuromodulation surgeries, external neurostimulation, and neuromodulation surgeries. Nerve grafting has been further classified as autografts, allografts, and xenografts. Based on end user, the market has been divided into end user, hospitals & clinics, ambulatory surgery centers, and others.

Market Players

Market Research Future (MRFR) recognizes Boston Scientific Corporation, LivaNova PLC, Axogen Corporation, Integra LifeSciences, Abbott, Stryker Corporation, Nuvectra Corporation, NeuroPace, Polyganics, and Medtronic as the key players in the global nerve regeneration market.

Regional Analysis

The global nerve regeneration market, based on the region, has been separated into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is anticipated to hold the largest share of the global nerve regeneration market during the forecast period. This is owing to the presence of key market players; strategic acquisitions by major players for enhancing product portfolio; increasing cases of chronic pain, obesity, and addiction; and availability of technologically advanced devices for the diagnosis and treatment of nerve disorders.

Europe is expected to witness significant growth in the nerve regeneration market. Various factors such as an increase in the healthcare expenditure by these nations and wide adoption of nerve regeneration techniques due to their efficiency to reduce pain and increasing cases of cancer are propelling the market growth.

Asia-Pacific is projected to be the fastest-growing region in the global nerve regeneration market due to increasing awareness of neurological disorders and their risk factors, rising prevalence of osteoporosis, cancer, and neurological disorders. According to an article published by the International Osteoporosis Foundation, osteoporosis affects almost 70 million Chinese citizens over the age of 50 and is responsible for nearly 687,000 hip fractures in China each year.

The nerve regeneration market in the Middle East & Africa region is likely to exhibit the lowest growth due to factors such as large patient population suffering from neurological disorders, technological advancements, growth of the healthcare sector, and increasing healthcare expenditure.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/nerve-regeneration-market-1202

Non-Invasive Monitoring Device Market Competitive Intelligence Analysis 2020-2027

The global sales of non-invasive monitoring devices market report asserts the market to remain steady on account of the increasing prevalence of cardiovascular and neurovascular diseases. Market Research Future (MRFR)’s latest study reveals that the global non-invasive monitoring device market is set to expand at 6.8% CAGR during the forecast period (2017–2023). While the product demand in advanced economies enters a maturity phase, countries such as China, India, and Australia have emerged as the new growth avenues for industry players. In the recent years, the adoption of non-invasive medical technologies has increased, particularly in regions such as Asia Pacific, South America, and Europe.

Factors such as favorable reimbursement policies and rising geriatric population are likely to play a crucial role in boosting growth of the market during the forecast period, especially in advanced economies. This primarily due to the presence of numerous private and government-backed insurance firms in developed countries. For instance, over 50 private insurance companies are present in the U.S. which have policies that cover more than 75% of the cost of the devices and treatment. For instance, if the average cost of the single device is approximately USD 10,000, then USD 7,500 is reimbursed under the U.S. Medicare plan. Other developed countries such as the U.K., Canada, and Germany are also introducing similar reimbursed policies.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1506

Global Market for Non-Invasive Monitoring Device – Segmental Analysis

MRFR’s report offers a detailed segmental analysis of the market based on type, modality, application, end-user, and region. By type, the market has been segmented into cardiac monitoring devices, brain monitoring devices, blood pressure monitoring devices, anesthesia monitoring devices, blood glucose monitoring devices, and others. In 2016, the cardiac monitoring device segment held the largest share, representing a market value of USD 6,232.4 million. By modality, the market has been segmented into tabletop and wearable. The tabletop segment accounted for the largest share in 2016 and is expected to grow significantly during the forecast period. By application, the market has been segmented into cardiology, neurology, and oncology. Among these, the cardiology segment accounts for the largest market share and is likely to remain highly lucrative throughout the assessment period. By end-user, the market has been segmented into hospitals and clinics, diagnostic centers, research & academic institutes, and others. The hospitals & clinics segment is likely to retain its top position towards the end of 2023.

Regional Outlook

The global non-invasive monitoring device market, on the basis of region, is segmented into the Americas, Europe, Asia Pacific and the Middle East and Africa. The Americas currently account for the largest share in the global non-invasive monitoring device market. This is majorly attributed to factors such as the presence of major manufacturers, increasing prevalence of cardiovascular diseases, technological advancement in non-invasive monitoring segment, raising awareness among the population and high disposable income. Asia Pacific currently accounts for the second largest market share. Presence of a large number of medical device manufacturers, (low-cost manufacturing) low manufacturing cost, cost-competitive labor, developing healthcare infrastructure, and increasing geriatric populace are some of the factors propelling the market in the region.

The Europe market is the third largest market for non-invasive monitoring devices. Factors such as recent healthcare developments, improving economies, improving per capita income, increased healthcare spending, and governmental support for R&D are influencing the growth of the market. The Middle East and Africa with less economic developments and extremely low income accounted for the least market share in 2016 but is expected to grow, as people living in this region are becoming more aware and demand for better treatments.

Global Market for Non-Invasive Monitoring Devices – Competitive Dashboard

Some of the key players profiled in the report include General Electric Company, Medtronic Plc, KONINKLIJKE PHILIPS N.V, Abbott, Omron Corporation, Vaso Corporation, Integrity Applications, CAS Medical Systems, Inc., A&D Medical Inc., Tensys Medical Inc., OrSense Ltd., CNSystems Medizintechnik AG, NIMedical, and Advanced Brain Monitoring, Inc.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/non-invasive-monitoring-device-market-1506

Sunday, 11 July 2021

Healthcare IoT Security Market Growth, Trends and Value Chain 2020-2027

The Global Healthcare IoT Security Market is expected to register 39.44% CAGR and is anticipated to reach USD 130,629.55 Million by 2025. Individuals today are using various kinds of networked devices to learn more about their health and daily regime. Home monitoring of aging population related to medical emergencies and medical adherence has become possible due to the increasing use of mHealth applications and smart pills.

However, the rewards of IoT also comes with the aspect of concern regarding the security and the privacy of the patient healthcare data. Mobile and wearable devices, pacemakers, insulin pumps, and other medical systems in the IoT create more access points prone to hackers. The security solutions and services play a critical role for the healthcare organizations to perform vulnerability management and secure the protected health information passing from IoT devices to the healthcare organizations.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/946

Market Dynamics

The market for healthcare IoT security is expected to register double-digit growth during the forecast period. The major factors influencing the growth of the market include increased data privacy concerns among consumers, increased government concerns over healthcare IoT security, increased usage of smart devices for health management and increased proliferation of cybercrimes in healthcare.

With the emergence of IoT in healthcare, consumers can now track their health in real time and simultaneously share healthcare information with their caregivers and healthcare organizations. However, the ease and usage of these devices are also raising security concerns among consumers. As the use of IoT increases, data privacy concerns are bound to increase and hence, will act as a key driver for the healthcare IoT security market, globally.

Segmentation

The global healthcare IoT security market has been segmented into components, security type, application.

Based on component, the global market is divided into solution and service.

Based on solution type, the global market has been segmented into analytics, encryption, data loss protection, identity and access management, unified threat management, and others.

Based on service type, the global market has been segmented into consulting services, risk assessment services, design & integration services, managed security services, and others.

Based on security type, the global market is segmented into application security, cloud security, endpoint security, network security, others security.

Based on application, the global market is segmented into pharmaceutical, medical devices, and biotechnology.

Key Players

The prominent players in the global healthcare IoT security market are Inside Secure SA, IBM Corporation, Cisco Systems Inc., Intel Corporation, Oracle Corporation, Sophos Group plc, Symantec Corporation, Trend Micro Inc, Checkpoint Software Technology, Kaspersky Labs, Fortinet Inc, Intelen Inc, Eurotech SpA, Deutsche telekom AG, SecureFLO LLC, Dell Corporation, Atmel Corporation, Security Mentor, Klynveld Peat Marwick Goerdeler, Agile Cyber Security Solutions, LLC.

Some of the key strategies followed by the players operating in the global healthcare IoT security market are innovation, product development, acquisition, and expansion.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/healthcare-iot-security-market-946

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Intracranial Pressure (ICP) Monitoring Market 2020 Industry Key Players, Trends, Sales, Supply, Demand, Analysis & Forecast By 2027

Intracranial pressure (ICP) monitoring is used in treating patients suffering from severe brain injury. In this process a sensor device is been used and placed inside the head to measure the pressure inside the skull and send it to a recording device

Intracranial pressure monitoring can be performed in following three ways:

Intraventricular Catheter: is the most accurate method. In this method Intraventricular Catheter is inserted through a hole in the skull and place in the lateral ventricle.

Subdural Screw: In this method hollow screw is placed in the skull. It is placed between a membrane that protects the spinal cord and the brain.

Epidural Sensor: The Epidural Sensor is placed between the skull and dural tissue by drilling a hole in the skull

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/703

Intracranial pressure monitoring (ICP) market Application:

Intracranial pressure (ICP) monitoring is mainly used in hospitals for patients suffering from brain injury, meningitis and intracerebral hemorrhage. There are multiple ICP products that have been used in hospitals such as Surgical Instruments, IAP-Monitoring, Hydrocephalus, CSF drainage and many more.

The microtransducers and ventriculostomy is included invasive method whereas tympanic membrane displacement, transcranial Doppler, CT scan/ MRI, optic nerve sheath diameter, and fundoscopy is included in noninvasive methods

Intracranial pressure (ICP) monitoring market growth influencer:

The major growth drivers of Intracranial pressure monitoring market is increasing global incidence and prevalence of neurological disorders, rising awareness about neurodegenerative diseases, technological advancements in brain monitoring devices and growing incidence of traumatic brain injuries.

The shortage of trained professionals, high cost of complex brain monitoring devices, unfavorable reimbursement policies and concerns regarding the accuracy of diagnostic devices are the major restraints of ICP market.

Intracranial pressure (ICP) monitoring market segmentation:

ICP monitoring market segmentation can be done by method, market, Instrument, applications and End-users.

ICP monitoring market by Method: Invasive and Non- invasive

ICP monitoring market by Market: external ventricular drain, fiber optic monitor, strain gauge transducer and air-pouch device market.

ICP monitoring market by Instrument: Devices and accessories

ICP monitoring market by Applications: Traumatic Brain Injury, Intracerebral Hemorrhage, Meningitis, and Subarachnoid Hemorrhage

ICP monitoring market by End-users: Trauma centers, hospitals, clinics and diagnostic laboratories.

Intracranial pressure (ICP) monitoring market major players:

Natus Medical Inc. (U.S.), Nihon Kohden Corporation (Japan), Philips Healthcare (Netherlands), GE Healthcare (U.K.), Siemens Healthcare (Germany), Compumedics Ltd. (Australia), Electrical Geodesics Incorporated (U.S.), Medtronic Inc. (Ireland), CAS Medical Systems, Inc. (U.S.) and Advanced Brain Monitoring (U.S.)

The reports also covers brief analysis of Geographical Region includes:

Americas: North America: US, Canada; Europe: Western Europe: Germany, France, Italy, Spain, U.K, Rest of Western Europe; Eastern Europe: Poland, Russia; Asia– Pacific: Asia: China, India, Japan, Rest of Asia; Pacific Countries: Australia, New Zealand; The Middle East& Africa.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/intracranial-pressure-monitoring-market-703

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Clinical laboratory Test Market Growth, Trends and Value Chain 2020-2027

The Global Clinical Laboratory Test Market is expected to register 6.5% CAGR to reach USD 324508.8 Million by 2022.

Clinical laboratory testing has emerged as a rapidly growing segment in healthcare over the past few years. Clinical laboratory testing includes all routine check-ups and other pathology tests for the diagnosis of various diseases ranging from CBC and other routine blood tests to anatomical, pathological testing, molecular, immunological, drug testing, and other tests for disease diagnosis and treatment.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1649

CBC and other routine blood tests are the most common type of tests that are used for screening certain disorders leading to an increase or decrease of cell counts. These tests help to diagnose a broad range of conditions from anemia and infections to cancer. Increasing prevalence of diseases and growing awareness and concerns regarding health issues all around the globe are the primary reasons for the growth of these routine check-ups and overall clinical laboratory testing market. On the other hand, the major factor restricting the growth of market is the strict government rules and regulations regarding laboratory testing. The global market has significant growth opportunities due to the various untapped therapeutic testing markets.

Market Dynamics

The global clinical laboratories market is segmented by routine medical testing includes full-body testing includes eye check-up, blood test, diabetes testing, and others; anatomical pathology testing includes histological analysis and urinalysis; esoteric medical testing includes tests for infrequent diseases; diagnostic imaging testing includes radiation procedures such as X-ray, CT, MRI, and ultrasound used for diagnosing the patient’s condition through imaging of internal organs.

Currently, around 617 million people, which is approximately 8.5% of people worldwide are aged 65 and over. According to the report “An Aging World: 2015,”, this percentage is expected to jump to nearly 17% by 2050 (1.6 billion). This is the primary reason for the swift growth of clinical laboratories. Besides these, other factors responsible for driving the clinical laboratory market are physician contribution to improve laboratory testing by counseling the patient for a screening of uncertain diseases or symptoms.

Segmentation

The global clinical laboratory tests market is segmented into types of laboratories, types of test, and region. Based on types of laboratories, the global clinical laboratory tests market is segmented into hospital-based laboratories, central/independent laboratories, physician office-based laboratories, and others. Based on types of test, the global market is segmented into complete blood count (CBC), basic metabolic panel (BMP), HbA1c tests, HGB/HCT tests, comprehensive metabolic panel tests, BUN creatinine tests, renal panel tests, electrolytes testing, liver panel tests, and lipid panel tests. Based on application, the global market is segmented into parasitology, virology, hematology, toxicology, immunology/serology, histopathology, and urinalysis. Based on end user, the global market is segmented into hospital-based laboratories, stand-alone laboratories, and clinics-based laboratories.

Regional Analysis

The clinical laboratory market is witnessing significant growth in developing and developed countries such as the UK, the US, China, India, and Spain.

The global clinical laboratory test market, based on region, is segmented into North America, Europe, Asia-Pacific, and the Middle East & Africa. There is a widespread presence of diseases related to hypertension, cardiovascular diseases, cancer, stroke, and other fatal diseases, due to which the expenditure on healthcare and R&D is the highest in North America, followed by Europe. The use of clinical laboratories by research institutes, hospitals, and clinics have increased the demand for clinical laboratories across the world. Asia-Pacific is the fastest-growing market in clinical laboratory tests due to the large geriatric population in China and Japan.

Key Players

The prominent players in the global clinical laboratory test market are AURORA Diagnostics, Laboratory Corporation of America, LifeLabs Medical Laboratories, Quest Diagnostics, and Sonic Healthcare.

The players operating in the global clinical laboratory test market are focusing on product launches and expanding their global footprints by entering untapped markets.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/clinical-laboratory-test-market-1649

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Stroke Post Processing Software Market to Witness Widespread Expansion During 2020-2027

Stroke Post Processing Software Market is projected to list a CAGR of 6.48% to influence income generation of USD 1,294.24 Million by 2024. A stroke can be defined as the absence of blood flow to brain tissues, resulting in vascular assembly within the brain. Furthermore, increasing awareness regarding the benefit of stroke post-processing software in individuals and healthcare professionals would create more demand for these products, boosting the global stroke post-processing software market’s growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8208

Market Highlights

The Global Stroke Post Processing Software Market is expected to register a CAGR of 6.48% during the forecast period, with a market value of USD 898.87 Million in 2018. A stroke can be defined as the lack of blood flow to brain tissues and can occur in any vascular structure within the brain.

The collaborations between start-up companies & big market players in the industry, increasing burden of ischemic strokes, and growth in the geriatric population are likely to contribute to the growth of the market during the assessment period. For instance, in January 2019, iSchemaView and NeuroLogica, a subsidiary of Samsung Electronics Co., Ltd and leader in medical imaging technology, collaborated to integrate iSchemaView’s RAPID cerebrovascular imaging platform with NeuroLogica’s portable CereTom CT scanners for use in MSUs and ICUs across the globe. However, stringent regulatory policies is likely to restrain the market growth during the forecast period.

Segment Analysis

The global stroke post processing software market, by installation, has been segmented into the desktop, mobile phones, and tablets. By modality, the market has been segregated into CT Scan and MRI. Based on type, the market has been divided into the ischemic stroke, hemorrhagic stroke, and others. On the basis of the end user, the global stroke post processing software market has been classified as hospitals & clinics, specialty centers, and others. The hospitals and clinics segment accounted for a value of USD 479.89 million in 2018.

Regional Analysis

Geographically, the global stroke post processing software market has been categorized as Europe, the Americas, Asia-Pacific, and the Middle East & Africa. Europe is expected to hold the largest share of the global stroke post processing software market. This is due to the presence of a well-developed healthcare infrastructure. Moreover, European companies offering stroke post processing software are getting involved in collaborations, mergers, and product launches to gain substantial market share, which in turn is positively affecting market growth. Americas showed a considerable amount of growth in the market due to the presence of an established healthcare system and two major stroke post processing software companies in the US, namely Viz.ai, Inc. and iSchemaView, Inc. Asia-Pacific is estimated to be the fastest-growing region in the global market due to the presence of some rapidly developing economies. Also, the availability of scientific expertise in Asia-Pacific is likely to contribute to market growth. The large patient pool for heart diseases in Asia-Pacific creates additional opportunities for market growth. Japan held a share of 28.5% in the Asia-Pacific stroke post processing software market in 2018. Also, the market in the Middle East & Africa is expected to demonstrate slow growth.

Market Players

Market Research Future (MRFR) recognizes the following companies as key players in the global stroke post processing software market that include Brainomix (UK), Viz.ai, Inc. (US), iSchemaView, Inc. (US), General Electric Company (US), Koninklijke Philips NV (Netherlands), and Siemens (Germany).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/stroke-post-processing-software-market-8208

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Articaine Hydrochloride Market Foraying into Emerging Economies 2020-2027

The Global Articaine Hydrochloride Market is expected to register 8.5% CAGR and is anticipated to reach USD 1,889.0 million by 2025.

Articaine is a form of a local amide anesthetic that is most commonly used in dentistry. The articaine is marketed as a colorless liquid in vials/cartridges (2ml in each vial/cartridge). It is available in two variants, i.e., Articaine-100 & Articaine-200. Articaine-200 is more potent than Articaine-100. The dosage can be based on the type and extent of surgical procedure, depth of anesthesia, degree of muscular relaxation, and condition of the patient. For pediatric patients, dosage based on their age, weight, the physical condition of the patient, and the extent of the surgical procedure.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2542

The articaine hydrochloride industry is growing rapidly. Articaine, with its greater ability to diffuse through tissues, become a very widely used local anesthetic in the European and Canadian markets.

Market Dynamics

Articaine hydrochloride is the most popular local anesthetic for dentistry. For example, in Germany, around 97% of the anesthetic used by dentists is articaine hydrochloride. The growth of the market is likely to be driven by increasing incidences of dental caries and other periodontal diseases, advancement in dental anesthesia delivery system device, increasing the use of articaine for dental surgery, innovative nature of the dental anesthetics industry, and vigorous research and development efforts. Periodontal disease is one of the major dental diseases that influence human populations worldwide at high prevalence rates. Periodontal diseases are more prevalent in Asia-Pacific. Lack of the most basic oral health education and limited availability of simple interventions like pain relief and emergency care for acute infection and trauma to the vast majority of the population, especially in the rural areas are major reasons for the high incidences of periodontal diseases in the region. According to the FDI World Dental Federation, more than 80% of people in Asia-Pacific, including countries such as India, Bangladesh, Nepal, Malaysia, and Indonesia, suffer from dental decay. Furthermore, 40–59% of the population in China and Australia suffer from dental caries.

Some of the popular local anesthesia other than articaine are prilocaine, lidocaine, mepivacaine, and bupivacaine. The availability and usage of alternative products are likely to thwart the growth of the articaine hydrochloride market during the forecast period.

Segmentation

The global articaine hydrochloride market has been segmented into application and end user. Based on application, the global market has been segmented into infiltration, nerve block, and others. Based on end-user, the global market has been segmented into dental clinics, hospitals, and academics & research institutes. The dental clinics segment accounted for a market value of USD 798.5 million in 2018.

Key Players

The prominent players in the global articaine hydrochloride market are 3M (US), Anhui BBCA Pharmaceutical Co., Ltd. (China), Dentsply Sirona (US), Inibsa Dental S.L.U (Spain), Jinan Chenghui Shuangda Chemical Co., Ltd. (China), Jinan Ruixing Pharmaceutical Technology Co., Ltd (China), Manus Aktteva Biopharma LLP (India), Pfizer Inc. (US), Pierrel S.p.A (Italy), Sanofi (France), Septodont (France), Siegfried AG (Switzerland), and Sigma Aldrich (US).

Some of the key strategies followed by the players operating in the global articaine hydrochloride market were innovation, product development, acquisition, and expansion.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/articaine-hydrochloride-market-2542

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com